Allied Corp Signs Agreement to Enable Offering of GMP Certified Products

KELOWNA, British Columbia, May 05, 2023 (GLOBE NEWSWIRE) -- Allied Corp. ("Allied" or the “Company”) (OTCQB: ALID) is pleased to announce that it has signed an agreement with a GMP certified partner in Switzerland that will enable Allied to be able to offer products with the GMP (Good Manufacturing Practices) approved certifications.

Allied has entered into an agreement with a large company that holds a Swiss Medic narcotics and processing license that will enable Allied’s Colombian produced medical cannabis to be offered into countries that require GMP certified products.

Allied’s clients and supply channel partners span five (5) world continents that include Australia, Europe, Asia, South America and North America. Allied's relationships with international partners are based on sustainable, long-term agreements that were designed with the Allied Inside supply chain in mind.

“We are proud to say that our Colombian production has now met vendor qualification approval for several vendors. Given that we are now able to offer GMP products opens many additional commercial relationships and markets.” said Calum Hughes, CEO and Chairman of the Board.

About Allied Corp. – CLICK HERE

Click here for Allied Inside business model website: CLICK HERE

Allied Corp. is an international cannabis company with its main production center in Colombia and is one of the few companies that has exported from Colombia internationally and the first company to export commercial cannabis flower from Colombia. By leveraging the Colombian advantages, Allied offers consistent supply of premium cannabis product at scale and attractive prices, while meeting high quality standards, thus significantly de-risking its partners supply chain. In addition to this, Allied has three CBD-brands to market with products selling in the United States.

Investor Relations:
[e-mail]
1-877-255-4337

Forward-Looking Statements:
This press release contains “forward-looking information” within the meaning of applicable securities laws in Canada or the United States ( “forward-looking information”). Forward-looking information may relate to the Company’s future outlook and anticipated events, plans or results, and may include information regarding the Company’s objectives, goals, strategies, future revenue or performance and capital expenditures, and other information that is not historical information. Forward-looking information can often be identified by the use of terminology such as “believe,” “anticipate,” “plan,” “expect,” “pending,” “in process,” “intend,” “estimate,” “project,” “may,” “will,” “should,” “would,” “could,” “can,” the negatives thereof, variations thereon and similar expressions. The forward-looking information contained in this press release is based on the Company’s opinions, estimates and assumptions in light of management’s experience and perception of historical trends, current conditions and expected future developments, as well as other factors that management currently believes are appropriate and reasonable in the circumstances. Forward looking statements in this press release include the following: that Allied is leveraging the conditions in its Colombia grow operation and future Kelowna location to support its Research and Development efforts; that Allied is making important strides forward to position itself as a leader in the medical cannabis space, that Allied intends to make a series of proposed trademark and other intellectual property protection filings, as part of the Company’s Intellectual Property and Pharma Development (IP&PD) Strategy, statements respecting the joint development, manufacturing, and the introduction of TACTICAL RELIEF branded products.